首页> 外文期刊>BMC Infectious Diseases >Prevalence and genotype distribution of HPV infection among 214,715 women from Southern China, 2012–2018: baseline measures prior to mass HPV vaccination
【24h】

Prevalence and genotype distribution of HPV infection among 214,715 women from Southern China, 2012–2018: baseline measures prior to mass HPV vaccination

机译:中国南部214,715名妇女HPV感染的患病率和基因型分布,2012 - 2018年妇女:大规模HPV疫苗接种前的基线措施

获取原文
       

摘要

The epidemiology on the human papillomavirus (HPV) among females in Southern China is not well-established. Baseline data on the prevalence of HPV infection in China prior to mass prophylactic HPV vaccination would be useful. Thus, this study aims to determine the type-specific HPV prevalence and distribution among females from Southern China prior to mass HPV vaccination. A retrospective cross-sectional study employing 214,715 women attending ChenZhou NO.1 People’s Hospital for cervical screening during 2012–2018 was conducted prior to widespread HPV vaccination. HPV genotype was detected using nucleic acid molecular diversion hybridization tests. The overall prevalence, age-specific prevalence, type distribution, and annual trend were analyzed. The overall HPV prevalence was 18.71% (95% confidence interval [CI], 18.55–18.88%) among Southern China females. During 2012–2018, the prevalence of HPV infection showed a downward tendency, from 21.63% (95% CI, 21.07–22.20%) in 2012 to 18.75% (95% CI, 18.35–19.16%) in 2018. Age-specific HPV distribution displayed a peak at young women aged less than 21?years (33.11, 95% CI, 31.13–35.15%), 20.07% (95% CI, 19.70–20.44%) among women aged 21–30?years, 17.29% (95% CI, 17.01–17.57%) among women aged 31–40?years, 17.23% (95% CI, 16.95–17.51%) among women aged 41–50?years, 21.65% (95% CI, 21.11–22.20%) among women aged 51–60?years, and 25.95% (95% CI, 24.86–27.07%) among women aged over 60?years. Of the 21 subtypes identified, the top three prevalent high-risk HPV (HR-HPV) genotypes were HPV52 (5.12%; 95% CI, 21.11–22.20%), ??16 (2.96%; 95% CI, 2.89–3.03%), and???58 (2.51%; 95% CI, 2.44–2.58%); the predominant low-risk HPV (LR-HPV) genotypes were HPV81 (1.86%; 95%CI, 1.80–1.92%) and???6 (0.69%; 95% CI, 0.66–0.73%) respectively. Incidence of HR-HPV only, LR-HPV only and mixed LR- and HR-HPV were 15.17, 2.07 and 1.47% respectively. Besides, single HPV infection accounted for 77.30% of all positive cases in this study. This study highlights 1) a high prevalence of HPV infection among females with a decreasing tendency towards 2012–2018, especially for young women under the age of 21 prior to mass HPV vaccination; 2) HPV52, ??16 and???58 were the predominant HPV genotypes, suggesting potential use of HPV vaccine covering these HPV genotypes in Southern China.
机译:南方南方人类人乳头瘤病毒(HPV)的流行病学并不完全成立。关于中国在大规模预防性HPV疫苗接种前中国HPV感染患病率的基线数据是有用的。因此,本研究旨在在大规模HPV疫苗接种之前确定来自南方南部的雌性的特异性HPV患病率和分布。在广泛的HPV疫苗接种之前,在2012-2018期间采用了214,715名郴州1人民医院的214,715名汉语筛查的妇女医院的回顾性横断面研究。使用核酸分子导流杂交试验检测HPV基因型。分析了整体患病率,年龄特异性患病率,型分布和年趋势。总体HPV患病率为18.71%(南方南方女性中的95%置信区间[CI],18.55-18.88%)。在2012 - 2018年期间,2012年的21.63%(95%CI,21.07-22.20%(95%CI,21.07-22.20%,2018年的21.63%(95%,18.35-19.16%)显示了下行趋势。特定年龄特异性HPV分布在少于21岁以下的年轻女性的峰值展示了峰值(33.11,95%CI,31.13-35.15%),21-30岁的女性,20.07%(95%CI,19.70-20.44%),17.29%(在31-40岁的女性中,95%CI,17.01-17.57%,年龄在31-40岁以下的妇女,17.23%(95%CI,16.95-17.51%),年龄在41-50岁以下的妇女,21.65%(95%CI,21.11-22.20% )在51-60岁以下的女性中,年龄在60岁以上的女性和25.95%(95%CI,24.86-27.07%)。在鉴定的21个亚型中,前三个普遍的高风险HPV(HR-HPV)基因型是HPV52(5.12%; 95%CI,21.11-22.20%),?? 16(2.96%; 95%CI,2.89-3.03 %)和??? 58(2.51%; 95%CI,2.44-2.58%);主要的低风险HPV(LR-HPV)基因型为HPV81(1.86%; 95%CI,1.80-1.92%),分别为-?? 6(0.69%; 95%CI,0.66-0.73%)。仅HR-HPV的发病率,LR-HPV仅和混合LR-and HR-HPV分别为15.17,2.07和1.47%。此外,单一HPV感染占本研究所有阳性病例的77.30%。本研究亮点1)女性HPV感染的高患病率降低了2012 - 2018年的趋势,特别是对于大众HPV疫苗接种之前21岁以下的年轻女性; 2)HPV52,?? 16和??? 58是主要的HPV基因型,表明潜在使用HPV疫苗在中国南方的这些HPV基因型。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号